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Abstract:
Recently published scientific articles have led to mixed nutritional advice on dietary
saturated fatty acids. Lesser et. al 2007 identified that mixed conclusions in scientific articles on
sweetened beverages can be attributed industry funding, as articles funded by the beverage
industry are four to eight times more likely to report conclusions in favor of the sponsor’s
products1. This thesis applies Lesser’s methods to determine whether industry funding influences
the inconsistent conclusions on saturated fatty acids. This thesis analyzed 100 articles on foods
high in dietary saturated fatty acids. While studies with food industry funding are more likely to
produce favorable conclusions, this trend is not significant (p= 0.205). On the other hand, the
odds ratio of a favorable versus an unfavorable conclusion in articles where investigators
disclosed a food industry related conflict of interest is 2.67 (95% CI, 1.03 to 6.88). The
prevalence of both industry funding and conflict of interest have increased over time, yet the
percent of articles reporting favorable conclusions has not changed over time. This suggests that
while industry funding and conflict of interest might skew nutrition research, the mixed
conclusions in articles on saturated fatty acids are largely influenced by other factors. Therefore,
all nutrition-related scientific articles on saturated fatty acids should be critically evaluated
before informing dietary recommendations.
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Introduction:
Food industry sponsored nutrition research has been associated with results that confirm
the benefits of the sponsor’s products. Lesser et. al 2007 explored this association by analyzing
206 articles on soft drinks, milk and juice.1 Lesser’s key finding was that articles funded by food
or beverage companies were four to eight times more likely to have conclusions favorable to the
financial interests of the sponsoring company. This thesis will modify the methods used by
Lesser in order to investigate whether food industry funding and conflict of interest are
associated with more favorable conclusions in nutrition studies on foods high in dietary saturated
fatty acids. Saturated fatty acids were chosen as the focus because there has been recent
controversy in scientific studies surrounding the health effects of saturated fatty acids.

The Biology of Saturated Fatty Acids
Dietary fats are a type of lipid constructed of triglycerides. Triglycerides consist of three
fatty acids attached to a glycerol backbone2. Triglycerides can be made up of saturated fatty
acids, those that contain only single bonds in its hydrocarbon chain, unsaturated fatty acids, those
that contain one or more double bonds, or a combination of the two (Figure 1). Saturated fatty
acids are considered to be ‘saturated’ with hydrogen because the maximum number of hydrogen
atoms are attached to the carbon skeleton. A fatty acid with one double bond is monounsaturated,
and one with multiple double bonds is polyunsaturated. These dietary fatty acids are a rich
energy source, a building blocks for the hormones needed to regulate bodily systems and a
carrier for fat-soluble vitamins2. Dietary saturated fatty acids are most often distributed as
palmitic acid, stearic acid, myristic acid and lauric acid (Figures 2-5)4. These saturated fatty
acids are found in a variety of foods. The effect of dietary saturated fatty acids on health
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outcomes in humans is typically studied by measuring the consumption of food sources (e.g.,
coconut oil) rather than the consumption of isolated saturated fatty acids (e.g., lauric acid).

Figure 1. A saturated fatty acid compared to a monounsaturated fatty acid3

Figure 2. Chemical structure of palmitic acid (16-carbon), a common dietary saturated fatty acid
found in palm oil and animal fats5.

Figure 3. Chemical structure of stearic acid (18-carbon), a common dietary saturated fatty acid
found in animal fats and cocoa butter6.

Figure 4. Chemical structure of myristic acid (14-carbon), a common dietary saturated fatty acid
found in various oils7.
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Figure 5. Chemical structure of lauric acid (12-carbon), a common dietary saturated fatty acid
found in various oils8.
The food sources with the highest percent saturated fatty acids - of the total fatty acid
composition - include butter fat (66%), coconut oil (92%), palm kernel oil (82%), cocoa butter
(61%), lard (42%) and other animal fats2. While these foods are high in saturated fatty acids,
each is a source of both saturated and unsaturated fatty acids. Therefore, the nutrition-related
scientific studies included in this thesis compare the health outcomes associated with consuming
foods high in saturated fatty acids versus consuming foods low in saturated fatty acids.
Moreover, the nutrition studies often measure health outcomes associated with high consumption
of the top sources of saturated fatty acids in the United States. These include dairy products such
as milk, butter and cheese, meat, eggs, and food processed with palm or coconut oil.9
While saturated fatty acids are difficult to isolate in nutrition studies, their effect on
biological and metabolic pathways has been studied in vitro and in animal models. Palmitic acid
and myristic acid are directly involved in protein fatty acid acetylation, a post-translational
modification of proteins4. Palmitic acid has also been shown to influence gene transcription
through recruiting transcription factors4. Additionally, saturated fatty acids have been shown to
be involved in lipogenesis, fat deposition, polyunsaturated fatty acids bioavailability and
apoptosis4.
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Dietary Saturated Fatty Acids, Cholesterol and Disease
Dietary saturated fatty acids are thought to increase plasma low density lipoprotein
(LDL) cholesterol concentrations, potentially increasing the risk for coronary heart disease. The
effect of saturated fatty acids, lauric acid and palmitic acid, and unsaturated fatty acids on serum
lipids and lipoproteins were studied in healthy women and men10. Saturated fatty acids
significantly increased blood LDL cholesterol levels when compared with unsaturated fatty
acids. This might be because saturated fatty acids have an effect on cell membrane fluidity. In
turn, saturated fatty acids might alter cholesterol synthesis and lipoprotein distribution. LDL
cholesterol is thought to be a potential risk factor for coronary heart disease. Epidemiological
studies have shown elevated levels of plasma LDL cholesterol and apolipoprotein B (apoB), the
main structural protein of LDL, to be associated with atherosclerosis11. LDL cholesterol is
thought to induce atherosclerosis through the generation of macrophage foam cells, or fat-laden
macrophages11. These foam cells participate in inflammatory responses and tissue remodeling
(Figure 6).

Figure 6. Potential mechanism for LDL and apoB involvement in atherosclerosis11

8

Recent studies suggest the potential lack of an association, or even an inverse association
between LDL cholesterol and mortality. In 2016, an analysis of 19 observational studies found
high LDL cholesterol to be inversely associated with mortality12. The results of this study
contradict the previous hypotheses that LDL cholesterol is atherogenic. Therefore, because
saturated fatty acids are thought to increase LDL cholesterol, this study calls question to whether
dietary saturated fatty acids increase the risk of heart disease. This thesis investigates whether
food industry funding influences theses conflicting conclusions in literature surrounding
saturated fatty acids, LDL cholesterol, and health outcomes.

History of Dietary Saturated Fatty Acid Research
A negative reputation was built around saturated fat following several studies performed
in the 1950s. These findings came about after the pioneering of ultracentrifugation to separate
lipoproteins13. Lipoproteins could be separated based on flotation rates in salt solutions, leading
to the terminology low density lipoprotein (LDL) and high density lipoprotein (HDL). In 1950,
the first literature was published suggesting the atherogenic potential of LDL, as there was
higher prevalence of coronary artery disease in people who had higher levels of LDL13. Dietary
fat was attributed as a key factor in this relationship. At the same time, physiologist Ancel Keys
began conducting comparative population-based dietary investigations focused on dietary fats
and saturated fatty acids14. In an observational study including data from seven countries, Keys
found a significant association between dietary saturated fat intake and heart disease mortality15.
These findings lead to the diet-heart hypothesis, or the idea that diets high in saturated fat and
cholesterol are a major cause of coronary heart disease16.
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Since the early research in the 1950s, the low-fat diet-heart hypothesis gained publicity
and even influenced dietary recommendations in the United States. A report published by the
American Heart Association (AHA) in 1957 claimed that diet may play an important role in the
pathogenesis of atherosclerosis. Specifically, the AHA suggested that dietary fat and the ratio
between saturated and unsaturated fat may be key determinants in this cardiovascular disease17.
A decade later, the AHA’s committee on nutrition published dietary recommendations including:
decrease saturated fats, increase polyunsaturated fats, reduce animal fat and reduce cholesterol.
In 1977, the U.S. Senate’s Select Committee on Nutrition and Human Needs furthered the
publicity of the diet-heart hypothesis18. The committee chair, George McGovern, stated that too
much fat, sugar and salt is directly linked to heart disease, cancer, obesity and stroke. Eventually
these recommendations were included in the first U.S. Dietary recommendations report in 1980.
More recently, similar to with LDL cholesterol, observational studies have shown an
inverse relationship between dietary saturated fatty acids and negative health outcomes. In 1997,
the Framingham Heart Study data showed higher saturated fat intake to be associated with
reduced stroke incidence in middle aged men19. In 2004, a review found greater saturated fat
intake to be associated with a lesser progression of coronary atherosclerosis in postmenopausal
women with relatively low total fat intake20. Further, this review attributed progression of
coronary atherosclerosis to a higher intake of carbohydrates; not saturated fats.
In 2010, Siri- Tarino et. al reopened the diet-disease hypothesis debate after taking a
second look at the evidence on the association between saturated fat and cardiovascular
disease21. Siri-Tarino published a meta-analysis of prospective epidemiological studies
concluding that there is no significant evidence that saturated fat is associated with
cardiovascular disease. The meta-analysis included data from 16 studies with congenital heart
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disease as an endpoint and 8 studies with stroke as an endpoint. It was noted that the lack of
association may be attributed to the reliance on the accuracy of dietary assessments, which varies
between studies. For example, it was noted that short term (4-7 day) food records are most
accurate, but generally 24-hour food recalls are most feasible in a large cohort. Siri-Tarino
questions whether the data collected in these nutrition studies accurately reflect long term dietary
patterns and health outcomes. This meta-analysis lead many others to question the evidence for
current dietary saturated fat recommendations.
Despite the recent nutritional controversy around saturated fat, the AHA has maintained
their campaign for the reduction of dietary saturated fatty acid consumption22. AHA recognizes
the controversy surrounding saturated fat but argues that many who question recommendations
rely on evidence from studies that the organization believes has methodological limitations 22.
Namely, the AHA claims that many studies do not take replacement nutrients into consideration
as when dietary saturated fat is decreased, another dietary component is increased. For example,
many studies compare a diet high in saturated fatty acids to a diet high in carbohydrates. This
makes it difficult to determine whether the differing health outcomes among study groups is
caused because of a decrease in saturated fat or an increase in carbohydrates.
Unlike the AHA, many others have changed their stance on saturated fatty acids. In 2010,
Harvard Heart Letter published an article called New Thinking on Saturated Fat that argues that
a healthy diet can include moderate saturated fat consumption 23. The article notes that the case
against saturated fat is based on high saturated fat diets increasing the cholesterol circulating in
the bloodstream inside LDL particles. Harvard Health notes that the connection between
saturated fat intake and supposedly harmful LDL cholesterol is difficult to measure when
saturated fat accounts for less than 10% of calories in the diet. Additionally, the article argues
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that saturated fat does not exist in a vacuum. Therefore, the mechanism by which saturated fat it
affects the body is determined by amount of cholesterol and polyunsaturated fat in the diet along
with exercise, genetics and environmental factors. Ultimately, this lead Harvard Health to argue
that there is much more to uncover about saturated fat before we can draw major conclusions23.
Others take it a step further and argue that an ideal diet should be high in saturated fatty
acids. The Perfect Health Diet, written by Dr. Paul Jaminet and Dr. Shou-Ching Jaminet named
saturated fatty acids the ‘safe fats’24. The book cites several studies to support their argument that
SFAs are not only nontoxic, but that they are beneficial. Ultimately, the science-based PHD diet,
recommends eating foods with high quantities of saturated fat for improved lipid profiles and
muscle mass.

Conflict of Interest in Scientific Research
It is possible that this recent mixed evidence on saturated fat could be attributed to the
funding source of studies and conflict of interest. Conflict of interest refers to when professional
judgement concerning a primary interest, such as the validity of research, is influenced by a
secondary interest, such as financial gain25.
The awareness of conflict of interests in medicine came about in the 1980s, following
new collaborations with universities and industry26. These relationships came to fruition as a
result of pressures of the federal budget, the growing pharmaceutical industry and incentives for
universities to develop discoveries commercially. This threatened the integrity of scientific
investigations and the public's trust in medicine. Therefore, several measures were taken to
restore this trust. For instance, in 1984, the New England Journal of Medicine announced that it
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would begin asking authors to disclose relationships with companies that could affect published
findings26.
Financial conflict of interest is also prevalent in the food and drug industries. Studies
sponsored by the pharmaceutical industry have been found to be four times more likely than
studies sponsored by other sources to produce outcomes favoring the sponsor27. Additionally, it
has been found that research funded by the pharmaceutical industry is less likely to be published
than studies funded by other sources. More recently, conflict of interest has gained attention in
nutrition research. Conflict of interest in nutrition research differs from the pharmaceutical
industry because drug companies have to submit the results of their studies to regulatory
agencies before the drug will be approved. Human foods nor nutrition labels are approved by the
FDA before being marketed 28. Rather, the FDA requires that 1) nutritional information must
appear on most foods and 2) all claims must be truthful. These requirements are not nearly as
stringent as those with drugs and biologics.
Adding to the problem, food companies are incentivized to fund research that will
increase consumer demand for their products. Of 204 research publications sponsored by CocaCola and Mars Center for Cocoa Health Science, the most common topic investigated was
physical activity (40.7%) as opposed to the health impact of sugar (10.8%).29 Research
sponsored by Coca-Cola and Mars appears to skew the evidence to support solutions (e.g.,
exercise) that do not involve reducing consumption of sugar. It is in the interest of these
companies that consumers to make positive lifestyle changes that do not involve reduction of
soda or candy consumption. For this reason, large food companies fund research that makes
claims beneficial to their product.
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Marion Nestle, nutrition professor at New York University and author of Unsavory
Truth: How Food Companies Skew the Science of What We Eat, blogged about several examples
of studies paid for by food businesses with a financial interest in the outcome of the study30. For
example, Mars, Inc. funded a study concluding that habitual intake of flavanols support healthy
cognitive function. Similarly, Juice Products Association funded a study concluding that fruit
juice delivers essential nutrients and phytonutrients. Additionally, Nestle writes about her own
financial relationships with food and beverage companies as a nutrition professor. Nestle thinks
carefully about conflicted situations, but writes that she is not wealthy enough to pay travel
expenses for regular conferences 31. She writes that she goes to meetings sponsored by food
companies, reads journal sponsored by food companies, receives frequent gifts, and accepts
reimbursements from food companies for travel. Nestle exemplifies that conflict of interest is
prevalent in nutrition research and might skew scientific evidence to support the sponsors.
An added challenge is that researchers are not always aware of their own biases. Dr.
Young, co-editor-in-chief of the Journal of Psychiatry and Neuroscience and professor at McGill
University writes, “We are not always aware of our own biases. The idea that scientists are
objective seekers of truth is a pleasing fiction, but counterproductive in so far as it can lessen
vigilance against bias.” 32 Therefore, it is very plausible that conflicting of interest in nutrition
research can influence the interpretation of the data and affect the takeaways stated in the
conclusion.

Food Industry Funding
The food industry continues to provide funding for nutrition research for several reasons.
For one, public research funds are limited and nutrition research usually does not qualify for
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biomedical funding from these public institutions33. Additionally, food companies are also
responsible for providing science-based evidence to support health claims on nutrition labels,
and sometimes for providing evidence that a product is safe34. All the while, academic
researchers that receive public funding are incentivized to partner with industry, as receiving
funds from diverse sources strengthens the case to receive tenure.
Though the food industry provides substantial funding for nutrition research, evidence
suggests that this does not influence the methodological quality of scientific research. A review
of 2539 articles in the American Association’s Evidence Analysis Library database was
performed to determine whether industry funding of nutrition research is associated with lower
research methodological quality35. Methodological quality was determined by the American
Diabetic Association using either a Primary Research Quality Criteria Checklist or Review
Research Quality Checklist. After controlling for research design, industry funded reports were
no more likely to receive a poor rating than those funded by government source.
In contrast to Lesser’s findings, not all research suggests that industry funding influences
conclusions. For example, one review investigated 79 obesity-related studies funded by either the
National Institute of Health or semi-public programs for Fluid Milk and Dairy36. The review did
not find consistent evidence that industry funding is associated with conclusions favorable to the
dairy products. However, the review found that NIH sponsored studies were the only ones to
report unfavorable conclusions, suggesting a publication bias in research sponsored by the food
industry. Additionally, the review noted that there is limited NIH funding available for research
specifically on dairy consumption and obesity. This suggests that a funding source might not
impact scientific research results, but rather the food industry might be more likely to fund
nutrition research with health outcome measures that could make their product seem desirable.
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Similarly, of 12 reports on industry funding in nutrition, industry sponsored studies were more
likely to have favorable conclusions than non-industry sponsored studies, but the results were not
significant37. Additionally, there were no associations with scientific methodological quality and
industry sponsorship. This thesis attempts to understand food industry funding and conflict of
interest as it relates to studies on foods high in saturated fat.

Public Perception of Saturated Fat
This thesis is relevant to the current health and nutrition landscape as there is a mixed
public perception of saturated fats. For instance, several popular fad diets advocate for high-fat,
low carbohydrate diets - including the Atkins diet, Ketogenic diet and the Perfect Health Diet. At
the same time, other diets and government nutrition recommendations advocate for limiting
certain types of fat. This is problematic as the public is receiving mixed messages about health
and nutrition, and there is scientific evidence to support both sides of the contradictory fat
claims.
There are several high-fat diets that are thought to be healthy and effective for weight
loss. For example, the Atkins diet, developed in the 1960s by a cardiologist, recommends
restricting carbohydrates and encourages eating a diet high in protein and fat38. Another high-fat
diet, the Ketogenic diet, is gaining publicity. Originally intended as a therapeutic diet for
children with epilepsy, the Ketogenic diet is being promoted for the general population by health
and fitness magazines39. These diets cite meta-analyses that claim low-fat diets do not lead to
long-term weight loss40. Similarly, the Perfect Health Diet, developed by Dr. Paul Jaminet and
Shou-Ching Jaminet, claims that saturated fatty acids can be eaten in high quantities. This diet
cites studies that show a lack of toxicity and reduced likelihood of stroke24. In contrast to these
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diets, the AHA recommends a moderate-fat diet replacing saturated fats with polyunsaturated
fats22.
With mixed messages from science, the media, and government organizations, there is no
question that knowledge surrounding dietary fat is conflicting. The general public appears to be
confused about which types of fats have health benefits. Of 6,426 subjects in 16 countries, 59%
think fat should be avoided41. Most subjects had heard of different types of fat such as ‘saturated
fat’, but the majority were unsure which types were healthiest. This confusion makes sense as the
scientific studies surrounding saturated fatty acids report mixed conclusions. Based on scientific
literature, it is unclear whether saturated fatty acids should be avoided, reduced, or consumed as
part of a healthy diet.
This thesis investigates whether industry funding and conflict of interest influence the
mixed evidence on saturated fat. Given the Lesser’s findings, I hypothesized that studies funded
by the food industry will be more likely to report favorable conclusions. However, knowing that
saturated fatty acids are difficult to isolate in human nutrition studies, I hypothesized that there
will be some variation in conclusions independent of the funding source. The goal of this report
is to better understand the factors influencing the mixed scientific evidence on saturated fatty
acids: be it industry funding, conflict of interest, or another factor.
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Methods:
Creation of Data Spreadsheet
Different from Lesser, I did not perform this study with multiple investigators. In order
to avoid potential biases, I created spreadsheet to separate selection of articles, classification of
conclusion and characterization of sponsor. A visual explanation of this process is included in
the appendix (Figures 11-13).
The spreadsheet contained the following tabs: 1) Raw Data, 2) Conclusion Classification,
and 3) Funding Source and Conflict of Interest. On the Raw Data tab, information was entered
upon selection of articles. These data include: 1) Article Title, 2) Random Number Code, 3)
Date, 4) Author, 5) Conclusion Raw Text, 6) Funding Raw Text and 7) Conflict of Interest Raw
Text. The ‘Random Number Code’ and ‘Conclusion Raw Text’ data was linked to the
‘Conclusion Classification’ tab. The ‘Random Number Code’, ‘Funding Raw Text’ and ‘Conflict
of Interest Raw Text’ data was linked to the ‘Funding Source and Conflict of Interest’ tab.
At least one day after raw data were entered, the raw text data on the ‘Conclusion
Classification’ tab were used to determine 1) Study Type, 2) Conclusion Classification, and 3)
Food Source of Fat. At least two days after raw data were entered and at least one day after
conclusions were classified, the raw text data on the ‘Funding Source and Conflict of Interest’
tab were used to determine 1) Funding Source and 2) Declared Conflict of Interest. The data on
the ‘Conclusion Classification’ and ‘Funding Source and Conflict of Interest’ tabs were linked to
‘Raw Data’. The final file used in Data Analysis included 1) Random Number Code, 2) Date, 3)
Study Type, 4) Conclusion Classification, 5) Food Source of Fat, 6) Funding Source and 7)
Declared Conflict of Interest.
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Selection of Articles
The search algorithm used to find articles was a modification of that used in a previous
meta-analysis of saturated fat and its association with mortality42. Interventional, observational
and scientific literature reviews were included in this analysis. Searches were conducted on the
U.S. National Library of Medicine’s PubMed. Searches were targeted at foods high in saturated
fatty acids (e.g., dairy, butter, meat, palm oil, cocoa, coconut oil) or saturated fatty acids (e.g.,
lauric acid, stearic acid). Additionally, searches looked for studies with endpoints measuring
health outcomes associated with saturated fatty acids (e.g., mortality, coronary heart disease,
high cholesterol). The search specified that studies must be limited to human studies in adults.
Studies included in the data analysis had to meet specific inclusion criteria. 1) Studies
must relate directly to dietary saturated fat. 2) At least one main endpoint must relate directly to
health, disease, or a disease marker. 3) The article must involve or consider research with
humans. 4) The conclusion must relate directly to the dietary saturated fat source under study.
For example, an article examining the effect of dietary fat on cardiovascular disease would be
included only if implications to the health effects of saturated fat consumption are stated
explicitly. 5) The article must be classified as an interventional study, an observational study, or
a scientific review. These classifications are outline in ‘Assessments of Covariates’ below.

Classification of Conclusion
As in the review conducted by Lesser, conclusions were classified as either Favorable,
Unfavorable or Neutral. Additionally, in this thesis, if a conclusion was unfavorable for saturated
fat, but favorable for unsaturated fat products, this was noted in the ‘Conclusion Classification’
column that linked back to raw data. This was considered as the funding source might benefit
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from consumers choosing to replace unsaturated fat with saturated fat. Conclusions were
classified as follows:
Favorable: Suggests beneficial health effects or absence of adverse health effects.
Unfavorable: Suggests adverse health effects or absence of beneficial health effects.
Neutral: Does not fit the criteria for favorable or unfavorable.
A conclusion would be classified as neutral if the conclusion suggested an absence of
adverse health effects but expressed strong doubts of the methodology of the study.

Characterization of Sponsor
As in the study conducted by Lesser, funding sources were classified as either Industry,
No Industry, Mixed or None Stated. Additionally, in this thesis, if a funding source was classified
as ‘Industry’, but the sponsor would benefit from consumers replacing saturated fats with
unsaturated fats (e.g., Canola Oil Board), a note was made in the ‘Funding Source’ column. The
funding sources were characterized as follows:
Industry: Solely for-profit and nonprofit affiliations with the food industry (e.g., US
National Dairy Council).
No industry: Solely governmental agencies with no industry association (e.g., US
National Institute of Health), university, independent foundations, philanthropies, and
other nonprofit organizations.
Mixed: Funding sources from both of the groups described above.
None Stated: If there was no mention of the source of the funding acquired for the study.
Ultimately, a total of 100 studies met the inclusion criteria (Figure 7). Of these 100
articles, 13 did not list a funding source. Of the 87 articles listing a funding source, 24% were
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funded entirely by industry, 66% were funded entirely with no industry support, and 10% were
funded by a mix of the two sources.

Figure 7. Flow diagram for inclusion of articles in the study
Characterization of Conflict of Interest
Extending upon the review conducted by Lesser, this analysis also noted whether studies
had a declared conflict of interest. This was classified as Yes if a conflict of interest was
declared. A note was made if the conflict of interest related to a party that would benefit from
consumers replacing saturated fats with unsaturated fats. This was classified as No, if there was a
statement claiming no conflict of interest. This was classified as None Stated if there was no
conflict of interest statement included in the study.

Assessment of Covariates
Two covariates were examined: publication year and article type. Publication year was
available on PubMed. Article type was classified according to the same definitions as in Lesser’s
21

study. Studies were classified as Interventional if a human consumed food with the intention of
measuring a biological response 1. Studies were classified as Observational if health outcome
data were collected on participants without intervention from the investigators1. Studies were
classified as Scientific Review if no original data were reported, but rather published research
was analyzed in a systematic fashion1.

Statistical Treatment
The relationship between conclusion and funding source was focused on discrete
categories of funding: either all industry benefit or no industry. Studies with industry antagonism
(e.g., Canola Oil Board) that would benefit from consumers perceiving unsaturated fatty acids as
a superior choice to saturated fatty acids were excluded from the analysis. Additionally, studies
with mixed funding were excluded because they represent a group with different proportions of
industry funding which could potentially obscure the relationship. Finally, studies with no listed
funding source were excluded from the study. The association between article conclusion and
funding source was evaluated using a Chi-Square test for nominal data.
Building off Lesser’s work, the relationship between conclusion and conflict of interest
was evaluated also focusing on the most discrete categories: all-industry benefit conflict of
interest and no conflict of interest. Studies with industry benefit funding were encompassed in
the studies with industry benefit conflict of interest. The studies where a note was made about
potential industry antagonism (e.g., Canola Oil Board) were excluded. Additionally, studies with
no conflict of interest statement were excluded. The association between article conclusion and
conflict of interest was evaluated using a Chi-Square test for nominal data.
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Additionally, the Odds Ratios (ORs) were computed of conclusions for all industry and
no industry funding. Two sets of ORs were computed. In the first, articles with favorable and
neutral conclusions were collapsed into one group, and in the other no neutral articles were
included. One article funded by all industry antagonism was originally categorized as
unfavorable; however, the sponsor was perceived to benefit from a negative conclusion about
products with saturated fat. Therefore, the article was reclassified as it was favorable to the
funder’s interests.
The ORs were computed of conclusions for conflict of interest and no conflict of interest.
The same as with funding source, two sets of ORs were computed. Five articles with all industry
antagonistic conflict of interest originally categorized as unfavorable, were reclassified as the
conclusions were favorable to the funder’s interests. ORs were determined to be statistically
significant if the 95% Confidence Interval was entirely greater than 1.
A p <0.05 (two tailed) was used as a criterion for statistical significance. Computations
were performed using RStudio 1.1.463 with the coin Package.
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Results
This analysis found that articles with food industry funding were more likely to produce
favorable conclusions; however, this trend was not significant (Table 1; Χ2(2)=3.168, p=0.205).
Similarly, favorable article conclusions were not significantly associated with industry benefit
conflict of interest (Table 2; Χ2(2)= 2.645, p= 0.266).

Table 1. Relationship between funding source and article conclusion (n=77)

Table 2. Relationship between conflict of interest and article conclusion (n = 86)

The OR for a favorable or neutral versus unfavorable conclusion, comparing all industry
to no industry support, was 1.68 (95% CI, 0.59 to 4.78). Eliminating neutral articles, the OR for
the same comparison was 2.35 (95% CI, 0.78 to 7.08). While neither of the ORs are statistically
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significant, these data suggest a higher likelihood of industry funded studies publishing
conclusions favorable to the company (Table 3).
Table 3. ORs for favorable conclusions of articles with all industry compared to no industry
support

The OR for a favorable or neutral conclusion versus an unfavorable conclusion,
comparing industry conflict of interest to no conflict of interest, was 2.52 (95% CI, 1.04 to 6.11).
Eliminating neutral articles, the OR for the same comparison was 2.67 (95% CI, 1.03 to 6.88).
These ORs are statistically significant and suggest a higher likelihood of authors with conflict of
interest publishing conclusions favorable to their competing interest (Table 4). The reason these
ORs are significant while the relationship (Table 2) is not has to do with the 5 studies with
industry antagonism. These studies were excluded in the Chi-Square test. These studies were
included in the OR calculations above, and the article conclusions were reclassified based on the
favorability related to the sponsor’s products.
Table 4. ORs for favorable conclusions of articles with industry conflict of interest compared to
no conflict of interest
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There were 100 articles included in the analysis. Of these studies, the majority were not
funded by the industry (57%) and half stated that investigators had no conflict of interest (Table
5). Most articles stated a funding source (87%) and included a conflict of interest disclosure
statement (91%). The analysis included a relatively even mix of interventional, observational and
scientific reviews. A large number of studies included were published within the last decade
(Figure 8).
Of the studies included, the percent of articles included reporting favorable conclusions
fluctuates overtime, with a slight peak in 2004-2007 (Figure 9). The percent of articles with
industry funding and conflict of interest has generally increased over time (Figure 10,11)
Table 5. General Descriptive Data of Articles Included in Study (n=100)
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Figure 8. Number of articles included by publication year

Figure 9. Percent of articles included reporting favorable conclusions by publication year
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Figure 10. Percent of articles included with stated industry funding by publication year

Figure 11. Percent of articles included with stated conflict of interest by publication year
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Discussion
The main finding of this thesis is that food industry funding does not significantly affect
conclusion favorability in nutrition-related scientific articles on foods high in saturated fat. While
studies funded by the food industry or with conflict of interest appear to report more favorable
conclusions, this trend is not significant. This is different from Lesser’s findings that scientific
articles on commonly consumed beverages funded entirely by industry are four to eight times
more likely to be favorable to the financial interests of the sponsors. Lesser noted that his team
could not be certain whether his findings are generalizable to all areas of nutrition1. This analysis
suggests that Lesser’s findings might not be translated to all nutrition studies.
This thesis also identified several secondary findings. First, there appear to be
inconsistencies in results of studies related to saturated fat independent of the funding source.
Second, industry antagonist funding from polyunsaturated fat companies may produce more
unfavorable conclusions contributing to the inconsistent results. Third, industry funding and
conflict of interest appear to be increasing over time.

Inconsistent Conclusions
This analysis suggests that there is a general variability in conclusions of saturated fat
studies, independent of industry funding source. Of the 100 studies included, 37% of the
conclusions were classified as favorable, 20% were classified as neutral and 42% were classified
as unfavorable. This variation appeared regardless of funding source. In studies funded by the
food industry, 37% of the conclusions were classified as unfavorable. This figure is similar to the
45% unfavorable conclusions in studies without industry. While there appears to be a slight trend
in the food industry publishing studies with more favorable conclusions, the data analyzed in this
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thesis do not suggest that this variability is significantly associated with funding source. Rather
the varying conclusions could stem from the difficulties in isolating saturated fat and the
methodological challenges in nutrition research.
The effects of saturated fatty acids are difficult to isolate; even when studies are
meticulously designed randomized control trials. For example, one study included in this
analysis compared the effects of polyunsaturated fatty acids with saturated fatty acids on liver
fat, and inflammation and adipose tissue expression of inflammatory and lipogenic genes43. The
study randomly assigned subjects to a diet high in polyunsaturated fats or saturated fats keeping
the overall macronutrient balance constant. The polyunsaturated fat group received foods rich in
n-6 linoleic acid including scones baked in sunflower oil, margarine, sunflower seeds, and
sunflower oil. The saturated fat group received foods rich in saturated fatty acids including
scones baked in butter. Despite being randomized and controlled, the effects of polyunsaturated
fatty acids versus saturated fatty acids were not isolated. Sunflower oil is not purely
polyunsaturated fatty acids - it can often contain up to 20% saturated fatty acids44. Likewise,
butter is approximately 61% saturated fatty acids and 33% unsaturated fatty acids44. Because it is
difficult to isolate saturated fatty acids, it is also difficult to measure their direct effects on
metabolism and health outcomes. This difficulty exists regardless of whether a study is funded
by the food industry or not. This could explain some of the inconsistencies in study conclusions.
Additionally, the difficulty with isolating the effects of saturated fatty acids is magnified
in observational studies. For example, a study included in this analysis investigated the
association of saturated fatty acids compared to unsaturated fatty acids and carbohydrates with
fatalities from coronary heart disease45. The study administered food frequency questionnaires to
84,628 women and 42,908 men every four years. These food frequency questionnaires asked
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how often participants had consumed specific foods in the past year. Participants were also asked
to specify the types of fat or oil used for baking and frying. Similar to randomized control trials,
no food is made up of purely unsaturated or saturated fatty acids. At the same time, these
memory dependent questionnaires may not yield accurate results being that participants are
providing estimates. The study’s investigators even noted that the observational study could not
prove causality. Further, the investigators explained that it is difficult to rule out residual
confounding factors, despite careful control for these lifestyle factors (e.g., exercise,
socioeconomic status, access to health insurance)45. The methodological challenges in isolating
the effects of a single nutrient in observational studies might also explain the variation in
conclusions among the studies analyzed.
The complex cellular and metabolic functions of saturated fatty acids likely add to the
inconsistencies in conclusions. One review of the functions of saturated fatty acids claims that
saturated fatty acids should no longer be considered a single group4. This review cites studies
demonstrating that individual saturated fatty acids, such as myristic acid and stearic acid, each
have different physiological and metabolic functions. For example, myristic acid is thought to
regulate polyunsaturated fat bioavailability and stearic acid is thought stimulate secretion of
lipoproteins involved in lipogenesis. It is argued that this variety in functionality demonstrates
that saturated fatty acids should not be considered one group in terms of structure, metabolism
and biological functions. The complex functions of saturated fatty acids might lead to different
health outcomes in different individuals and in different environments.
Beyond the challenges specific to studying saturated fatty acids, there are several
methodological challenges in all nutrition research. For one, it is difficult to gather the ‘gold
standard’ of evidence as outlined by evidence-based medicine through nutrition research. In the

31

evidence-based medicine model, highest quality of evidence is gathered from the well-conducted
and suitably powered multinational double-blind placebo-controlled randomized trial46. In this
type of study, the control group is a placebo that allows participants, investigators and study staff
to be blinded. In these studies, the data can demonstrate causality. While many clinical trials
investigating pharmaceuticals and biologics can meet this gold standard, the same is not feasible
for investigating macronutrients or specific foods. There is no believable ‘placebo’ for palm oil,
coconut oil, butter or meat. Therefore, nutritional research often uses comparison groups in
interventional studies. This was the case with many studies included in this analysis. For
example, several evaluated the effects of olive oil versus coconut oil. These comparison groups
make it difficult to isolate the effect of a single nutrient. For example, in the individuals that
consumed olive oil, it is difficult to separate the effects caused by the addition of polyunsaturated
fatty acids in olive oil or caused by the absence of saturated fatty acids in coconut oil.
Another challenge in nutrition research stems from the principle of energy balance in
nutrition and metabolism. Assuming the body expends consistent energy to sustain life and
perform physical work, caloric intake must remain constant to maintain body weight. Therefore,
in most nutrition studies, when the intake of one nutrient is increased another nutrient is
generally increased. This is not the same case in pharmaceutical research, where a clear dosedependent relationship can be measured. Pharmaceutical products can be given in high doses
without changing diet because consuming a drug does not increase calorie intake. This is not the
same for consuming meat or dairy. For example, if someone is given a high-fat diet intervention
(e.g., adding butter to their diet), the individual is likely to replace other nutrients such as
carbohydrates (e.g., reduction of bread eaten). Thus, it is difficult determine whether changes
from the baseline occur due to an increase in fat, a reduction in carbohydrates, or the two
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combined. Overall, while industry funding and conflict of interest might influence the
inconsistent conclusions on saturated fatty acids, methodological challenges are likely the greater
factor.

Polyunsaturated Fat Industry Antagonism
Several of the studies included in this analysis were funded by companies that would
benefit from distinguishing the health effects caused by polyunsaturated versus saturated fatty
acids. Moreover, these companies would benefit from consumers replacing saturated fatty acids
(e.g., butter) with polyunsaturated fatty acids (e.g., vegetable oils). Some of the industry
antagonistic funding sources included Kewpie Corporation (soybean oil) and the California
Walnut Commission. Of the 5 studies with industry antagonist funding, 100% reported
conclusions classified as ‘unfavorable’ to saturated fatty acids, but ‘favorable’ to the products of
the funding source. For example, California Walnut Commission would benefit from consumers
choosing ‘healthy’ polyunsaturated fatty acids in nuts over ‘unhealthy’ saturated fatty acids fats
in cheese. This thesis only included a small sampling of studies funded by companies’ with
interest in polyunsaturated fatty acids. Further research should be performed to better understand
this relationship.
Rise in Conflict of Interest
This analysis found a trend in increasing conflict of interest and industry funding within
nutrition studies over time. Likely contributing to this are the cuts in the NIH budget, now
funding only 1 out of 6 grant applications - the lowest rate in NIH history33. Industry funding of
nutrition research will likely continue to increase, therefore, researchers and journals should take
precautions in order to ensure integrity of nutrition research.
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This analysis identified cases that suggest the food industry sponsors research teams that
have a record of publishing results favorable to the sponsor. For example, the meta-analysis
performed by Siri Tarino et. al in January 2010 questioned the negative perception of saturated
fat stated that none of the investigators had a conflict of interest21. However, in November 2010,
the same team published a scientific commentary on saturated fatty acids. The disclosure
statement, just ten months later, stated that one of the investigators, Dr. Krauss, received grants
from the National Dairy Council, National Cattlemen's Beef Association, Robert C. and
Veronica Atkins Foundation, and the National Institutes of Health47. Similarly, Dr. Siri-Tarino
received a grant from the National Dairy Council47. This change in disclosure statements
suggests that industry sponsors saw the potential for Siri-Tarino’s team to publish research
beneficial to their products, and began sponsoring follow-up research. Therefore, while industry
sponsored research and conflict of interest might not be the cause of the variation of scientific
conclusions, companies might strategically invest in research by investigators likely to publish
results beneficial to the product of interest.

Methodological Strengths and Weaknesses
This thesis had several methodological strengths. First and foremost, this thesis modified
the methods of Lesser’s previously published paper and built follow-up research into the study.
This allowed for a systematic methodological approach. This thesis used Lesser’s study as a
baseline model for data collection and took the analysis in a different direction. It built off
substantial previous literature to investigate a different area of nutrition - saturated fatty acids as
opposed to sweetened beverages - over a greater period of time. Additionally, this study was
performed over a decade after the study by Lesser, therefore, many more studies disclosed
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funding source and conflict of interest. Only 13 out of the 100 studies included in this analysis
did not disclose funding source, whereas 95 of Lesser’s 206 studies included did not disclose
funding.
At the same time, this study had several methodological weaknesses. Unlike Lesser’s
study, this thesis was written with one investigator and without the consultation of a medical
librarian. Therefore, conclusions and funding sources were classified with one, rather than two
investigators’ opinion. While the creation of a locked tab, randomly numbered spreadsheet
helped mitigate potential biases, this analysis was missing a key secondary opinion. Lesser, on
the other hand, required the agreement of two investigators for discrete ‘favorable’ and
‘unfavorable’ conclusion classifications, otherwise the conclusion would be classified as
‘neutral’1. Additionally, this study looked at saturated fatty acids, rather specific food products.
Lesser looked at juice, milk and soda. The search algorithm identified articles on both specific
saturated fatty acids (e.g., palmitic acid, lauric acid) and food sources that are generally high in
saturated fatty acids (e.g., dairy, butter). Therefore, there was a greater range of studies that were
included in this thesis. Some studies measured the impact of specific saturated fatty acids on
cholesterol levels. Other studies looked at the association between diets high in saturated fat and
mortality using estimates with nutrition questionnaires. This range was exacerbated because
saturated fatty acids exist in a variety of different food products and their effects are generally
more difficult to isolate. For example, dairy products are high in dietary saturated fatty acids, but
also high in micronutrients like calcium and vitamin D. Therefore, the effects of saturated fat on
overall well-being is generally harder to isolate than the effects of consuming a sugary beverage.
Finally, the sample included in this study might have obscured underlying relationships. Of the
studies included, 21 were fully funded by the industry and 57 were not funded by the industry.
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Since the number of studies in each category were not tracked during the collection, these figures
were not known until after the data analysis. The sample of studies funded by the industry might
have been too small to accurately represent the full population.
While Lesser’s research provided a great baseline for the methods in this thesis, their
work received some criticism. Professor Martijn B Katan at the Free University of Amsterdam
writes that “an association between funding and outcome does not by itself prove bias”48. Katan
notes that five of the papers included in Lesser’s analysis that did not have industry funding dealt
with outbreaks of food poisoning. This strengthened the correlation of unfavorable outcomes
with the absence of industry funding. He also suggests that industry funding tends measure
positive health outcomes and that there might be cancellation or delay in publication when the
results are disappointing to the sponsor. Therefore, Katan argues that the relationship between
industry funding and nutrition research conclusions goes beyond publicly available data. Katan
disagrees with the general condemnation of industry-supported research48. He cites his own
experience working on research sponsored by Unilever that discovered the effects of trans-fatty
acids and a study sponsored by Nestle discovering the cholesterol-raising factor in unfiltered
coffee. Despite this, using Lesser’s methods as a baseline generally strengthened this thesis.

Implications and Future Directions
In the future, one could investigate the influence of industry funding in studies related to
both sugar, as in Lesser’s research, and dietary fatty acids. There is evidence that specific food
industries sponsor research to point the blame at a potential substitute product. For example, a
company that sells soda would benefit from the public perceiving fat as more harmful than sugar,
as this could influence customers to choose a soda over a milkshake. Likewise, the meat industry
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would benefit from the public perceiving high fat, low carbohydrate diets as better for weight
loss. This way, more consumers might replace calories from carbohydrates with saturated fat.
There is evidence to suggest that industry antagonism from the sugar industry contributed
to the negative perception of saturated fat. In fact, the Sugar Research Foundation played a key
role in forming the diet-heart hypothesis. During the same time Ancel Keys identified total fat,
saturated fat and cholesterol as a potential causal hypothesis for heart disease, another researcher
championed sugar as a potential cause49. A recent historical review looked at records from the
Sugar Research Foundation, and determined that the foundation initiated coronary heart disease
research in 196550. The SRF sponsored a review titled “Dietary Fats, Carbohydrates and
Atheroslerotic Disease”51. The review concluded that the dietary intervention required to prevent
coronary heart disease was reducing dietary cholesterol and replace saturated fat with
polyunsaturated fat. This research downplayed early warning signals that sucrose consumption
was a risk factor for heart disease and pointed the blame at saturated fatty acids. This suggests
that the review sponsored by the Sugar Research Foundation played a key role in shaping public
perceptions and influencing federal policy.
Food industry funding and conflict of interest might influence conclusion favorability
across different nutrients and food products. Therefore, the relationship between food industry
funding and scientific conclusions might be more complex that the relationship this thesis or any
other research has identified. In the future, it could be interesting to look at overall industry
dollar spending on scientific research across different food industries (soda, dairy, meat, oil) and
public perception of the healthfulness of the products. The degree to which the food industry
uses nutrition research as a product promotion strategy is unclear, and this thesis suggests that
there might be variation across industries. For instance, the sweetened beverage industry that
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Lesser investigated might sponsor more research than the Palm Oil Board, or other companies
with a vested interest in the perception of saturated fatty acids.
At the same time, this study suggests that companies selling products high in saturated fat
could be funding studies to point the blame back at sugars and complex carbohydrates. Several
studies included in this thesis concluded that saturated fatty acids had favorable health outcomes
when compared to carbohydrates. For example, one study investigated the impact of saturated
fatty acids in butter and cheese heavy diets on LDL and HDL cholesterol concentrations. Diets
high in polyunsaturated fats and carbohydrates were used as comparisons. The study concluded
that saturated fatty acids have similar effects on HDL cholesterol to the other diets and that
saturated fatty acids from dairy products have no significant effects cardio metabolic risk
factors52.
Therefore, studies with industry funding and conflict of interest should be evaluated
critically before being used to inform dietary recommendations and health policy. Because the
need for industry funding in nutrition funding is increasing, investigators, journals and policy
makers should continue thinking up ways to ensure the integrity of scientific research.
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Conclusion
Overall, this thesis did not uncover a statistically significant relationship between
industry funding and favorability of conclusions in studies on foods high in saturated fat.
However, the odds of a study performed by an investigator with a disclosed conflict of interest
was 2.67 times more likely to report a favorable conclusion than those with no conflict of
interest. Additionally, there were several secondary findings. Studies on saturated fat have
inconsistent and conflicting conclusions independent of funding source, industry antagonistic
funding studies be associated with more unfavorable conclusions on saturated fat and there
appears to be a rise in food industry conflict of interest. More research should be performed to
better understand conflict of interest in nutrition research. For the time being, nutrition-related
scientific articles on saturated fatty acids should be critically evaluated before being used to
inform dietary recommendations.

39

Works Cited
1. Lesser, L. I., Ebbeling, C. B., Goozner, M., Wypij, D. & Ludwig, D. S. Relationship between
Funding Source and Conclusion among Nutrition-Related Scientific Articles. PLOS Med. 4,
e5 (2007).
2. Food Fats and Oils. Institute of Shortening and Edible Oils e10 (2016).
3. Fatty Acids and Triacylglycerols. University of Washington Courses Web Server Available at:
https://courses.washington.edu/conj/membrane/fattyacids.htm. (Accessed: 13th November
2018)
4. Legrand, P. & Rioux, V. The Complex and Important Cellular and Metabolic Functions of
Saturated Fatty Acids. Lipids 45, 941–946 (2010).
5. Palmitic acid | C16H32O2 - PubChem. Available at:
https://pubchem.ncbi.nlm.nih.gov/compound/palmitic_acid#section=Top. (Accessed: 22nd
October 2018)
6. Pubchem. Stearic Acid. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/5281.
(Accessed: 22nd October 2018)
7. Pubchem. Myristic Acid. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/11005.
(Accessed: 22nd October 2018)
8. Pubchem. Lauric Acid. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/3893.
(Accessed: 22nd October 2018)
9. Top Food Sources of Saturated Fat in the U.S. The Nutrition Source (2012). Available at:
https://www.hsph.harvard.edu/nutritionsource/top-food-sources-of-saturated-fat-in-the-us/.
(Accessed: 24th September 2018)
10. Temme, E. H., Mensink, R. P. & Hornstra, G. Comparison of the Effects of Diets Enriched in
Lauric, Palmitic, or Oleic Acids on Serum Lipids and Lipoproteins in Healthy Women and
Men. Am. J. Clin. Nutr. 63, 897–903 (1996).
11. De Groot, L.J. et al. The Role of Lipids and Lipoproteins in Atherosclerosis NCBI
Bookshelf. Available at: https://www.ncbi.nlm.nih.gov/books/NBK343489/. (Accessed: 13th
November 2018)
12. Ravnskov, U. et al. Lack of an Association or an Inverse Association Between Low-DensityLipoprotein Cholesterol and Mortality in the Elderly: A Systematic Review. BMJ Open
(2016).

40

13. Gofman, J. W. et al. The Role of Lipids and Lipoproteins in Atherosclerosis. Science 111,
166–186 (1950).
14. Keys, A. Diet and the Epidemiology of Coronary Heart Disease. J. Am. Med. Assoc. 164,
1912–1919 (1957).
15. Keys, A. The Seven Countries Study: 2,289 deaths in 15 years. - PubMed - NCBI. Available
at: https://www.ncbi.nlm.nih.gov/pubmed/6739443. (Accessed: 8th October 2018)
16. Berge, L. & F, A. How the Ideology of Low Fat Conquered America. J. Hist. Med. Allied
Sci. 63, 139–177 (2008).
17. Page, I. H., Stare, F. J., Corcoran, A. C., Pollack, H. & Wilkinson, C. F. Atherosclerosis and
the Fat Content of the Diet. J. Am. Med. Assoc. 164, 2048–2051 (1957).
18. Dietary Goals for the United States Prepared by Committee on Nutrition and Human Needs.
Washington: US Government (1967).
19. Gillman, M. W., Cupples, L. A., Millen, B. E., Ellison, R. C. & Wolf, P. A. Inverse
Association of Dietary Fat with Development of Ischemic Stroke in Men. JAMA 278, 2145–
2150 (1997).
20. Mozaffarian, D., Rimm, E. B. & Herrington, D. M. Dietary Fats, Carbohydrate, and
Progression of Coronary Atherosclerosis in Postmenopausal Women. Am. J. Clin. Nutr. 80,
1175–1184 (2004).
21. Siri-Tarino, P. W., Sun, Q., Hu, F. B. & Krauss, R. M. Meta-analysis of Prospective Cohort
Studies Evaluating the Association of Saturated Fat with Cardiovascular Disease. Am. J. Clin.
Nutr. 91, 535–546 (2010).
22. American Heart Association, Inc. The Facts on Fats: 50 Years of American Heart
Association Dietary Recommendations. (2015).
23. Harvard Medical School. New Thinking on Saturated Fat. Harvard Health Publishing
(2010).
24. Jaminet, P. & Jaminet, S.-C. Perfect Health Diet: Regain Health and Lose Weight by Eating
the Way You Were Meant to Eat. Scribe Publications (2013).
25. Thompson, D. F. Understanding Financial Conflicts of Interest. N. Engl. J. Med. 329, 573–
576 (1993).
26. Lo, B., Field, M. J. & Institute of Medicine. Committee on Conflict of Interest in Medical
Research. National Academies Press (US), 2009).

41

27. Lexchin, J., Bero, L. A., Djulbegovic, B. & Clark, O. Pharmaceutical Industry Sponsorship
and Research Outcome and Quality: Systematic Review. BMJ (2003).
28. Food and Drug Administration. Is It Really ‘FDA Approved?’ Available at:
https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm047470.htm. (Accessed: 6th
November 2018)
29. Fabbri, A., Holland, T. J. & Bero, L. A. Food Industry Sponsorship of Academic Research:
Investigating Commercial Bias in the Research Agenda. Public Health Nutr. 1–9
(undefined/ed). doi:10.1017/S1368980018002100
30. Conflicts of Interest in Nutrition Research: Recent Examples. Food Politics by Marion Nestle
(2015).
31. Conflicts of Interest: Personal Examples. Food Politics by Marion Nestle (2015).
32. Young, S. N. Bias in the Research Literature and Conflict of Interest: An Issue for
Publishers, Editors, Reviewers and Authors, and It Is Not Just About the Money. J. Psychiatry
Neurosci. JPN 34, 412–417 (2009).
33. Kroeger, C. M. et al. Scientific Rigor and Credibility in the Nutrition Research Landscape.
Am. J. Clin. Nutr. 107, 484–494 (2018).
34. Nutrition, C. for F. S. and A. Labeling & Nutrition - Guidance for Industry: Evidence-Based
Review System for the Scientific Evaluation of Health Claims. Available at:
https://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/L
abelingNutrition/ucm073332.htm#system. (Accessed: 6th November 2018)
35. Myers, E. F., Parrott, J. S., Cummins, D. S. & Splett, P. Funding Source and Research Report
Quality in Nutrition Practice-Related Research. PLOS ONE 6, e28437 (2011).
36. Wilde, P., Morgan, E., Roberts, J., Schpok, A. & Wilson, T. Relationship between Funding
Sources and Outcomes of Obesity-related Research. Physiol. Behav. 107, 172–175 (2012).
37. Chartres, N., Fabbri, A. & Bero, L. A. Association of Industry Sponsorship With Outcomes
of Nutrition Studies: A Systematic Review and Meta-analysis. JAMA Intern. Med. 176, 1769–
1777 (2016).
38. Atkins Diet: What’s Behind the Claims? Mayo Clinic Available at:
http://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/atkins-diet/art-20048485.
(Accessed: 13th November 2018)
39. Keto Diet: Does It Really Work? | US News Best Diets. Available at:
https://health.usnews.com/best-diet/keto-diet. (Accessed: 13th November 2018)

42

40. Tobias, D. K. et al. Effect of Low-Fat vs. Other Diet Interventions on Long-Term Weight
Change in Adults: A Systematic Review and Meta-Analysis. Lancet Diabetes Endocrinol. 3,
968–979 (2015).
41. Diekman, C. & Malcolm, K. Consumer Perception and Insights on Fats and Fatty Acids:
Knowledge on the Quality of Diet Fat. Ann. Nutr. Metab. 54, 25–32 (2009).
42. O’Sullivan, T. A., Hafekost, K., Mitrou, F. & Lawrence, D. Food Sources of Saturated Fat
and the Association With Mortality: A Meta-Analysis. Am. J. Public Health 103, e31–e42
(2013).
43. Bjermo, H. et al. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and
inflammation in abdominal obesity: a randomized controlled trial. Am. J. Clin. Nutr. 95,
1003–1012 (2012).
44. Gunstone, F. D. Fatty Acid and Lipid Chemistry. (Blackie, 1996).
45. Li, Y. et al. Saturated Fat as Compared With Unsaturated Fats and Sources of Carbohydrates
in Relation to Risk of Coronary Heart Disease: A Prospective Cohort Study. J. Am. Coll.
Cardiol. 66, 1538–1548 (2015).
46. Bellomo, R. & Bagshaw, S. M. Evidence-based Medicine: Classifying the Evidence from
Clinical Trials – the Need to Consider Other Dimensions. Crit. Care 10, 232 (2006).
47. Siri-Tarino, P. W., Sun, Q., Hu, F. B. & Krauss, R. M. Saturated Fatty Acids and Risk of
Coronary Heart Disease: Modulation by Replacement Nutrients. Curr. Atheroscler. Rep. 12,
384–390 (2010).
48. Katan, M. B. Does Industry Sponsorship Undermine the Integrity of Nutrition Research?
PLOS Med. 4, e6 (2007).
49. Yudkin, J. Diet and Coronary Thrombosis Hypothesis and Fact. Lancet Lond. Engl. 273,
155–162 (1957).
50. Kearns, C. E., Schmidt, L. A. & Glantz, S. A. Sugar Industry and Coronary Heart Disease
Research: A Historical Analysis of Internal Industry Documents. JAMA Intern. Med. 176,
1680–1685 (2016).
51. McGandy, R. B., Hegsted, D. M. & Stare, F. J. Dietary Fats, Carbohydrates and
Atherosclerotic Vascular Disease. N. Engl. J. Med. 277, 245-247 concl (1967).
52. Brassard, D. et al. Comparison of the Impact of SFAs from Cheese and Butter on
Cardiometabolic Risk factors: A Randomized Controlled Trial. Am. J. Clin. Nutr. 105, 800–
809 (2017).

43

Appendix

Figure 11. A segment of the Raw Data Tab
The title, number code, authors, year, conclusion raw text, funding raw text and conflict of
interest raw text (columns in navy) were entered into the spreadsheet.
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Figure 12. A segment of the Conclusion Classification tab
The conclusion text (column in purple) showed the conclusion raw text from the Raw Data tab.
From this text study type, conclusion favorability and saturated fat source (columns in navy)
were classified. These categorizations linked back to the study type, conclusion classification and
fat source (columns in purple) on the Raw data tab shown in Figure 11.

Figure 13. A segment of the Funding Source and Conflict of Interest tab
The funding text and conflict of interest text (columns in purple), showed the respective raw
texts from the Raw Data tab. From this, funding source and declared conflict of interest (columns
in navy) were classified. These categorizations linked back to funding source and declared
conflict of interest (columns in purple) on the Raw data tab shown in Figure 11.
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Clarke, R., Frost, C., Collins, R., Appleby, P. & Peto, R. Dietary lipids and blood cholesterol:
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de Oliveira Otto, M. C. et al. Dietary intake of saturated fat by food source and incident
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